We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,179.00 +11.50 (+0.22%) Dow Futures
38,307.00 +69.00 (+0.18%) Nasdaq Futures
18,222.75 +43.50 (+0.24%) Russell 2000 Futures
2,030.20 +10.40 (+0.51%) Crude Oil
85.46 -0.20 (-0.23%) Gold
2,372.40 -1.70 (-0.07%)
FTSE 100 (^FTSE)
| Previous Close | 7,923.80 |
| Open | 7,923.80 |
| Volume |
| Day's Range | 7,923.80 - 8,044.98 |
| 52 Week Range | 7,215.80 - 8,045.00 |
| Avg. Volume | 1,103,865,101 |
The TelegraphOil hits six-month high as Israel braces for Iran attack
Oil prices have jumped to their highest level in six months amid reports Israel is bracing for a potential attack by Iran.
Yahoo Finance UKTrending tickers: BP, Gold, Samsung, Apple
The latest investor updates on stocks that are trending on Friday.
- Reuters
GLOBAL MARKETS-European stocks gain, dollar strong as traders cut Fed easing bets
European stocks were on track to race ahead of Wall Street on Friday, with exporter shares in high demand as the continent's major currencies dropped against a dollar standing tall on bets the U.S. Federal Reserve would keep interest rates high. Europe's broad Stoxx share index, rose 1.1% on Friday morning as a weak euro flattered the domestic value of exporters' dollar earnings. Money-market pricing implied investors expect the Fed to reduce its main funds rate by about 45 bps this year.
The TelegraphWhy I’m backing the British underdogs
I had little interest in the debate that stirred recently over the latest England football kit and its use – or lack of use – of the traditional St George’s flag. The story didn’t rile any strong feelings in me either way, and I am sure that when the Euros kicks off this summer there won’t be any grounds for complaints over a dearth of English flags across the country.
- Reuters
GLOBAL MARKETS-European stocks gain, dollar tall as traders cut Fed easing bets
European stocks were on track to race ahead of Wall Street on Friday, with exporters' shares in high demand as the continent's major currencies dropped against a dollar standing tall on bets the U.S. Federal Reserve would keep interest rates high. Money market pricing implied investors expect the Fed to reduce its main funds rate by less than 50 bps this year. U.S interest rates are at a 23-year high of 5.25%-5.5% and traders started 2024 betting on about 150 bps of cuts.
Yahoo Finance UKWall Street falls on weak consumer confidence while FTSE closes high
Tech companies lead the slide, while FTSE rises on end of recession hopes.
Yahoo Finance UKUK economy grows slightly in February
The UK economy grew for the first time since the summer, having slipped into recession at the end of 2023.
The TelegraphWorld risks ‘tepid Twenties’ as debt levels and inflation soar, warns IMF
The world is at risk of a “sluggish and disappointing decade”, the head of the International Monetary Fund has warned, while urging vigilance to restore price stability and jumpstart economic growth.
ReutersAstraZeneca CEO could earn 19 million pounds as pay measure clears opposition
High executive pay in Britain has long been contentious, particularly with pay for ordinary workers rising far more slowly, and Soriot's pay package has proved a lightning rod for investor discontent in the past. In 2021 — the last time AstraZeneca's long-term incentives policy was reviewed — almost 40% of votes were cast against it, and proxy advisory groups Glass Lewis and ISS also opposed the plan, as they did this year. Despite the notable no votes, the final result is a major boost to one of the best-paid executives among London's blue-chip FTSE 100 at a time when British firms are looking to match U.S. and European rivals' pay packages.
- Reuters
UPDATE 2-AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition
AstraZeneca shareholders on Thursday approved a 2024 pay policy which will boost CEO Pascal Soriot's remuneration to as much as 18.9 million pounds ($23.7 million) this year, but over a third of investors revolted against the huge sum. High executive pay in Britain has long been contentious, particularly with pay for ordinary workers rising far more slowly, and Soriot's pay package has proved a lightning rod for investor discontent in the past. In 2021 — the last time AstraZeneca's long-term incentives policy was reviewed — almost 40% of votes were cast against it, and proxy advisory groups Glass Lewis and ISS also opposed the plan, as they did this year.
